JSPR Q3 2025 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JSPRJasper Therapeutics, Inc.

$23M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$19M

Net Income

-$19M

EPS (Diluted)

$-1.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$57M

Total Liabilities

$46M

Stockholders' Equity

$12M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$19M	-$20M	+3.6%
Net Income	-$19M	-$19M	-0.5%